One Source of Truth for Every Drug Your Business Cares About
70+
Real-Time
FDA & EMA
Built for every stage of a drug’s IP lifecycle
and patent family trees together and sets them up around the work your team is responsible for.
Plan your generic launch & market entry
Work out a precise launch window by combining standard patent expiries with pediatric extensions and SPC applications.
180-Day Exclusivity Opportunities
Find the products where you can be first to file and earn 180 days of generic exclusivity.
Revenue Cliff & Market Potential Modeling
Compare patent expiries with past global revenue to model generic market erosion. Then focus on the launches with the highest return.
Regulatory Exclusivity Expiration Audits
Know when orphan drug, pediatric, and new chemical entity protections run out. Where you can get around the patents, this is the date that decides your launch.
Patent Expiry Opportunities
Plan your route to market as blockbuster small molecules and biologics near their final patent expiry.
Freedom-to-Operate & Paragraph IV Defense
Don’t let a Hatch-Waxman complaint or PTAB petition take you by surprise. Follow active infringement cases, inter partes reviews, and settlements, with court dockets kept in sync.
Hatch-Waxman & Paragraph IV Notice Radar
Get an alert as soon as a generic company makes a Paragraph IV certification. Its notice letter starts the 45-day window for filing a complaint.
PTAB Trial (IPR / PGR) Status Tracking
Follow institution decisions, cross-appeals, and the final written decisions that rule on claim validity and patentability.
Unified Patent Court (UPC) Global Sync
Audit enforcement actions, opt-outs, and revocation suits across the 17+ EU member states that take part in the UPC.
Docket Entries & Primary Document OCR
Read verified pleadings, civil cover sheets, and cross-appeals without leaving your portfolio dashboard. Scanned filings come through as searchable text.
Patent Lifecycle & Exclusivity Defense
Protect brand revenue by tracking and auditing term extensions around the world. That covers Patent Term Adjustments (PTA), Patent Term Extensions (PTE), and Supplementary Protection Certificates (SPC).
Patent Term Adjustment (PTA) Audits
Calculate the days added under 35 U.S.C. 154(b) because of USPTO processing delays, and review recalculation windows.
Patent Term Extension (PTE) Tracking
Track extensions under 35 U.S.C. 156 that make up for regulatory review delays and restore up to 5 years of exclusivity on FDA-approved products.
European SPC & Pediatric Additions
Follow national SPC filings and 6-month pediatric extensions across Europe’s major markets.
Orange Book Listing & Delisting Alerts
Audit chemical entity classifications, use code updates, and administrative disputes over patent delistings, with data taken from the FDA.
Competitor Monitoring & Patent Intelligence
Watch what competitors are filing across countries, regions, and therapeutic areas in real time.
Citation monitoring
Get notified when a competitor’s patent cites one of yours. It shows which R&D areas they’re working on.
Portfolio expansion strategies
Track competitors’ moves into new markets and the formulation changes they make to build patent thickets.
R&D Focal Area & Filing Velocity Trends
Study several years of filing pace by therapeutic indication to see a competitor’s pipeline shift coming.
Geographic filing strategies
Find out where competitors have secured protection and where they’ve left openings.
Inside the Elixir dashboard
check changes to FDA exclusivities, and follow Hatch-Waxman filings as they come in.
Patent Family Tree
Complete File History
Threat Indicators
Orange Book & EMA
Litigation & PTAB
Real-Time Email Alerts
Global Coverage with ELIXIR Family Tree
You’ll get regular email alerts on all the important patent and regulatory events. They come from sources such as the USPTO, Orange Book, Green Book, EPO, EMA, IPO, WIPO, and the Korean Green List, plus other country-specific patent and regulatory databases.
The family tree ties together patent families, ownership structures, subsidiaries, related companies, and portfolio changes across countries. It gives your team the complete patent picture for each drug, with the context to read it and data it can trust.
How Elixir links one drug across countries
USPTO patent updates
Catch US filings, continuations, continuations-in-part, and grants as soon as they appear.
Orange Book and Green Book monitoring
We collect and match FDA listings and Health Canada’s database around the clock.
EPO and EMA activity tracking
We monitor European Patent Office docket filings and EMA exclusivity data in full.
IPO and WIPO patent updates
Map PCT filings worldwide and get status updates from the Indian Patent Office.
Korean Green List monitoring
Get a full view of the patent lists kept by South Korea’s Ministry of Food and Drug Safety.
Family tree-based global portfolio tracking
Our interactive map links each parent filing to all of its children worldwide.
Periodic email alerts
Each alert is a visual summary you can scan at a glance, set up around your team’s portfolio tags.
Country-wise patent & regulatory activity
We run local data checks in more than 70 national patent registers.
What sets Elixir apart
Elixir runs AI monitoring across countries around the clock, and experienced pharma analysts review the results as they come in.
Highly Customizable
Set up monitoring by product, company, technology, patent portfolio, therapeutic area, or jurisdiction. Choose your own alert thresholds, so the alerts you get are the ones worth reading.
Easy to Use
Find your way around a clear dashboard with simple legal-to-commercial workflows, smart compound search, alerts you can act on, one-click spreadsheet exports, and timeline reports ready for executives.
Automation + Expert Review
Elixir pairs AI patent monitoring with careful manual review by senior pharma patent analysts. False positives get filtered out, so the competitive intelligence you receive has been validate
How each team uses Elixir
Pick your role to see what Elixir does for you.
Win first-to-file generic exclusivity, and don’t commit money to a product before you know whether its patent thicket can be challenged.
Use all 45 days of the statutory response window, with competitor filings and court dockets tracked for you.
Find territories with no blocking patents, and confirm how long a candidate asset can be enforced.
Get the most revenue out of your own formulations by securing every term adjustment the law allows.
How Elixir helped companies like yours?
Optimised notifications are useful to see all jurisdictions events
Elixir team provides a fast solution for any customisation
Critical events notification on same day with the next action to take
Best tool for monitoring drug patents in a centralized system
More on drug patents & genric entry insights
Your drug patents and exclusivities on one dashboard
Monitor active drug patents, legal status, exclusivities, Hatch-Waxman filings, regulatory updates, and competitor moves worldwide from a single screen. Here’s a preview.
Revenue data, built into the patent view
Elixir connects the money to the patents. Sales data sits on the same map as patent protection, so you can size up what a multi-million-dollar patent cliff means for biosimilar and generic markets in every region.
Sales volumes update as they change and line up against global expiry timelines, in interactive charts that are easy to read.
Drug revenue trends
Compare patent expiries with past global earnings and market potential.
Market potential
Forecast the size of the generic market share after exclusivity ends, using specialized market-volume projections.
Product performance
Follow sales trends for biologics, biosimilars, and small molecules across countries.
Commercial impact of patent expirations
Use past revenue erosion models to estimate the value of your generic launch or your defensive brand launch.
Competitor product portfolios
Get clean commercial profiles that combine therapeutic sales with live patent maps.
Designed for High-Exclusion Pharma Decision Making
Every team involved in a launch gets its own dashboard modules, mapped to your company’s launch strategy.
Pharmaceutical Companies
Enterprise Access
Generic Drug Manufacturers
Enterprise Access
IP Counsel Teams
Enterprise Access
Licensing & Business Development Teams
Patent Attorneys
Competitive Intelligence Teams
R&D Organizations
Investment and Strategy Teams
Common questions
Answers about Elixir’s features, how we validate data, and how we map your pipeline.
What is a Pharma Patent Monitoring Tool?
It’s a platform that tracks patent filings, grants, lawsuits, and regulatory exclusivities around important drug compounds as they happen. A standard patent search engine finds patents. A monitoring tool links each marketed drug to the patents and exclusivities that protect it. It then turns complex legal events into business openings, such as generic launch windows, freedom-to-operate checks, and Paragraph IV opportunities.
Does ELIXIR monitor Orange Book patents?
Yes. We run automated checks on the FDA Orange Book every day. You get an immediate alert for new patent listings, delistings, changes to patent use codes, and regulatory exclusivity updates, such as New Chemical Entity (NCE), orphan drug, and pediatric extensions. We cross-check this data with registries in other countries, including Health Canada’s patent register.
Can Elixir track litigation?
Yes. Elixir monitors US District Court filings, including Hatch-Waxman infringement suits and Paragraph IV certifications. The same goes for PTAB inter partes reviews (IPR), post-grant reviews (PGR), and the case registers of Europe’s Unified Patent Court (UPC). You’ll get a notification as soon as a case docket opens or changes.
How many countries does Elixir cover?
Elixir gives you competitive intelligence across more than 70 jurisdictions. That includes the major patent offices, such as the USPTO, EPO, WIPO, JPO, and CNIPA, along with the main regional health authorities and official gazettes. You get a full view of high-value markets and of the countries where generic manufacturers are emerging
Discover what ELIXIR Can do for Your Team
Track the pharma patents that matter to you and find generic launch openings that are easy to miss. Check regulatory exclusivities every day, follow Hatch-Waxman cases, and stay ahead of competitor pipelines around the world.
- Custom gazettes, built around your therapeutic classes.
- 100% validated data, with two rounds of checks to filter out false positives.
- More than 70 countries covered, with databases linked across borders.
Book your pipeline audit
Tell us where things stand, and we’ll take it from there.